Charles Ryhee
Stock Analyst at TD Cowen
(2.46)
# 2,341
Out of 5,172 analysts
17
Total ratings
60%
Success rate
10.88%
Average return
Main Sectors:
Stocks Rated by Charles Ryhee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CVS CVS Health | Maintains: Buy | $73 → $80 | $71.48 | +11.92% | 5 | Nov 25, 2024 | |
| MCK McKesson | Maintains: Buy | $563 → $652 | $885.84 | -26.40% | 4 | May 8, 2024 | |
| CVX Chevron | Maintains: Outperform | $185 → $170 | $201.73 | -15.73% | 3 | Feb 24, 2023 | |
| EVH Evolent Health | Maintains: Outperform | $57 → $59 | $2.58 | +2,186.82% | 2 | Jan 30, 2023 | |
| CAH Cardinal Health | Maintains: Market Perform | $59 → $72 | $207.83 | -65.36% | 1 | Aug 16, 2022 | |
| TDOC Teladoc Health | Maintains: Outperform | $240 → $188 | $5.35 | +3,414.02% | 1 | Aug 9, 2021 | |
| OSCR Oscar Health | Initiates: Market Perform | $29 | $12.63 | +129.61% | 1 | Mar 29, 2021 |
CVS Health
Nov 25, 2024
Maintains: Buy
Price Target: $73 → $80
Current: $71.48
Upside: +11.92%
McKesson
May 8, 2024
Maintains: Buy
Price Target: $563 → $652
Current: $885.84
Upside: -26.40%
Chevron
Feb 24, 2023
Maintains: Outperform
Price Target: $185 → $170
Current: $201.73
Upside: -15.73%
Evolent Health
Jan 30, 2023
Maintains: Outperform
Price Target: $57 → $59
Current: $2.58
Upside: +2,186.82%
Cardinal Health
Aug 16, 2022
Maintains: Market Perform
Price Target: $59 → $72
Current: $207.83
Upside: -65.36%
Teladoc Health
Aug 9, 2021
Maintains: Outperform
Price Target: $240 → $188
Current: $5.35
Upside: +3,414.02%
Oscar Health
Mar 29, 2021
Initiates: Market Perform
Price Target: $29
Current: $12.63
Upside: +129.61%